Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1503863

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Darent Valley Hospital
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the ONS publication entitled How the population changed in Dartford: Census 2021, published on 28 June 2022, if he will review the capacity of Darent Valley Hospital in the context of an above national average population increase in the local area in the period 2011 to 2021.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	45469
	answer	answer is ministerial correction date of answer 27/09/2022 answer text <p>The Health and Care Act 2022 established 42 Integrated Care Boards (ICBs) in England. ICBs empower local health and care leaders to integrate planning and provision of services and will produce five-year joint forward plans with partner National Health Service trusts and foundation trusts to respond to local health needs. This may include consideration of the needs of a changing population.</p><p>There are no current plans to review the capacity of Darent Valley Hospital. Kent and Medway ICB are responsible for planning and commissioning healthcare services, including inpatient acute and emergency and urgent care services.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 27/09/2022 15:11:51 answering member 4320 label Biography information for Robert Jenrick
	tabling member	1522 label Biography information for Adam Holloway

1503915

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Neurology: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of the clinical guidance on the (a) diagnosis and (b) treatment of functional neurologic disorders.
	tabling member constituency	South Leicestershire
	tabling member printed	Alberto Costa
	uin	45534
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>There are no plans to make a specific assessment. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for developing evidence-based guidance for the health and care system. NICE has produced clinical guidance to support clinicians in the diagnosis of functional neurological disorder (FND). The ‘Suspected neurological conditions: recognition and referral’ guideline, published in 2019, addresses the initial assessment of symptoms and signs which might indicate a neurological condition, including FND. The guideline is available at the following link:</p><p><a href="http://www.nice.org.uk/guidance/ng127" target="_blank">www.nice.org.uk/guidance/ng127</a></p><p>NICE is also developing a guideline on rehabilitation for chronic neurological disorders, which will include FND. NICE expects to publish the final guideline in December 2023.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 22/09/2022 15:29:07 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4439 label Biography information for Alberto Costa

1505443

	registered interest
	date	06/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Digital and NHS England
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of the merger of NHS England and NHS Digital on the current workforce of both bodies.
	tabling member constituency	Nottingham North
	tabling member printed	Alex Norris
	uin	48480
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>NHS England, NHS Digital and Health Education England will be merged from 1 April 2023. The merger will be managed through statutory transfer orders which will be developed as part of the secondary legislation for all staff employed by NHS Digital and Health Education England transferring to NHS England. A programme to oversee the merger has been established. The organisational design work currently underway will determine the impact on the current workforce and also the future workforce needs of the new organisation. We expect that by the end of 2023/24 the new NHS England will be at least 30% and up to 40% smaller than the current combined size of NHS England, Health Education England and NHS Digital.</p> answering member constituency Newark answering member printed Robert Jenrick grouped question UIN 48481 question first answered 22/09/2022 15:05:00 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4641 label Biography information for Alex Norris

1505445

	registered interest
	date	06/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Digital and NHS England
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment the Department has made of the potential impact on contractors of the merger of NHS England merger and NHS Digital.
	tabling member constituency	Nottingham North
	tabling member printed	Alex Norris
	uin	48481
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>NHS England, NHS Digital and Health Education England will be merged from 1 April 2023. The merger will be managed through statutory transfer orders which will be developed as part of the secondary legislation for all staff employed by NHS Digital and Health Education England transferring to NHS England. A programme to oversee the merger has been established. The organisational design work currently underway will determine the impact on the current workforce and also the future workforce needs of the new organisation. We expect that by the end of 2023/24 the new NHS England will be at least 30% and up to 40% smaller than the current combined size of NHS England, Health Education England and NHS Digital.</p> answering member constituency Newark answering member printed Robert Jenrick grouped question UIN 48480 question first answered 22/09/2022 15:05:00 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4641 label Biography information for Alex Norris

1503413

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Attention Deficit Hyperactivity Disorder: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that patients who require treatment for Attention deficit hyperactivity disorder and similar conditions will not been impacted by potential disruptions to the supply chains for the prescription medications they require.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	45098
	answer	answer is ministerial correction date of answer 27/09/2022 answer text <p>The Department has well established procedures to deal with supply issues with prescription medicines and works with the Medicines and Healthcare products Regulatory Agency, NHS England and industry to prevent shortages and ensure that any risks to patients are minimised should they arise.</p><p>We are aware of supply issues with some medicines used in the treatment of attention deficit hyperactivity disorder. However, alternative products remain available and communications have been issued to the National Health Service to provide advice.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 27/09/2022 15:36:57 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4658 label Biography information for Alex Sobel

1503849

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Trials: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Life Science competitiveness indicators 2022, published in July 2022, what assessment he has made of the performance of the UK in the metric for median time from clinical trial application and the first patient receiving a first dose for a subset of commercial trials.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	45598
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>The annual Life Sciences competitiveness indicators have highlighted that trial establishment times in the United Kingdom are slower than several of our competitors. In 2022, indicators showed that the median time was 247 days for a subset of commercial trials, with the UK ranked seventh out of 10. In March 2021, we published ‘Saving and Improving Lives: The Future of UK Clinical Research Delivery’ which highlighted improving the speed and efficiency of study set-up. This is being taken forward through the Recovery Resilience and Growth Programme. The Programme’s delivery partners are simplifying and streamlining processes to improve the median time from clinical application and first patient.</p><p>In 2021, a combined review by the Health Research Authority (HRA) and the Medicines and Healthcare products Regulatory Agency (MHRA) reduced approval times for clinical trials to 61 days, compared to 90 days for those that did not go through combined review. ‘The Future of UK Clinical Research Delivery: 2022 to 2025 implementation plan’, published on 30 June 2022, includes actions designed to improve set-up times over the remainder of this Parliament, including:</p><p>- Implementing the UK-wide National Contract Value Review for commercial research to ensure costing does not delay study set-up in the National Health Service;</p><p>- Introduction of a single UK approval service to replace the HRA and Health Care Research Wales’ approval and equivalent processes in Northern Ireland and Scotland; and</p><p>- Further development of the Integrated Research Application System by the HRA and the MHRA to streamline health technology and medicines research.</p> answering member constituency Newark answering member printed Robert Jenrick grouped question UIN 45435 question first answered 22/09/2022 14:16:09 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4658 label Biography information for Alex Sobel

1503850

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Trials: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Life science competitiveness indicators published in July 2022, what steps his Department is taking to reduce the median time from clinical trial application to the first patient receiving a first dose for a subset of commercial trials.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	45435
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>The annual Life Sciences competitiveness indicators have highlighted that trial establishment times in the United Kingdom are slower than several of our competitors. In 2022, indicators showed that the median time was 247 days for a subset of commercial trials, with the UK ranked seventh out of 10. In March 2021, we published ‘Saving and Improving Lives: The Future of UK Clinical Research Delivery’ which highlighted improving the speed and efficiency of study set-up. This is being taken forward through the Recovery Resilience and Growth Programme. The Programme’s delivery partners are simplifying and streamlining processes to improve the median time from clinical application and first patient.</p><p>In 2021, a combined review by the Health Research Authority (HRA) and the Medicines and Healthcare products Regulatory Agency (MHRA) reduced approval times for clinical trials to 61 days, compared to 90 days for those that did not go through combined review. ‘The Future of UK Clinical Research Delivery: 2022 to 2025 implementation plan’, published on 30 June 2022, includes actions designed to improve set-up times over the remainder of this Parliament, including:</p><p>- Implementing the UK-wide National Contract Value Review for commercial research to ensure costing does not delay study set-up in the National Health Service;</p><p>- Introduction of a single UK approval service to replace the HRA and Health Care Research Wales’ approval and equivalent processes in Northern Ireland and Scotland; and</p><p>- Further development of the Integrated Research Application System by the HRA and the MHRA to streamline health technology and medicines research.</p> answering member constituency Newark answering member printed Robert Jenrick grouped question UIN 45598 question first answered 22/09/2022 14:16:09 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4658 label Biography information for Alex Sobel

1507039

	registered interest
	date	20/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Trimethylaminuria
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether her Department has made an assessment of the adequacy of funding for research into methods for (a) treating and (b) curing Trimethylaminuria.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	51933
	answer	answer is ministerial correction date of answer 27/09/2022 answer text <p>No specific assessment has been made. The Department funds the majority of research through the National Institute for Health and Care Research (NIHR). While the NIHR has not funded any studies into the treatment and cure of trimethylaminuria in the last five years, it has supported the delivery of two such studies via its infrastructure.</p><p> </p><p>The NIHR’s expenditure on research is more than £1 billion per year, with research proposals competing for the funding available. Applications are subject to peer review and judged in open competition, with awards made based on the importance of the topic to patients and health and care services, value for money and scientific quality.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 27/09/2022 12:10:13 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4658 label Biography information for Alex Sobel

1522930

	registered interest
	date	17/10/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Surgery: Leeds North West
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help reduce waiting times for elective surgeries in Leeds North West constituency.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	64301
	answer	answer is ministerial correction date of answer 25/10/2022 answer text <p>The ‘Delivery plan for tackling the COVID-19 backlog of elective care’ how the National Health Service will recover and expand elective services over the next three years, including in Leeds North West. We have allocated more than £8 billion from 2022/23 to 2024/25, in addition to the £2 billion Elective Recovery Fund and £700 million Targeted Investment Fund already made available in 2021/2022 to increase elective activity. This funding aims to deliver the equivalent of approximately nine million additional checks and procedures and 30% further elective activity by 2024/25 than pre-pandemic levels. A proportion of this funding will be invested in workforce capacity and training and we have committed to invest £5.9 billion for new beds, equipment and technology.</p><p>The target to eliminate waiting times of two years or more for elective procedures was met in July 2022 and we aim to eliminate waiting time of eighteen months or more by April 2023. This will be achieved through increasing capacity, seeking alternate capacity in other trusts or the independent sector and engaging with patients to understand choices made regarding their care.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 25/10/2022 16:49:25 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4658 label Biography information for Alex Sobel

1522935

	registered interest
	date	17/10/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Leeds North West
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what (a) financial and (b) other steps her Department is taking to help tackle NHS workforce shortages in Leeds North West constituency.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	64306
	answer	answer is ministerial correction date of answer 25/10/2022 answer text <p>The Department has commissioned NHS England to develop a long-term workforce plan. The plan will consider the number of staff and the roles required and will set out the actions and reforms needed to improve workforce supply and retention, including in Bermondsey and Old Southwark, Ellesmere Port and Neston, Leeds North West and Dulwich and West Norwood.</p> answering member constituency Newark answering member printed Robert Jenrick grouped question UIN 64104 64149 64223 question first answered 25/10/2022 11:23:46 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4658 label Biography information for Alex Sobel